VRNA

Verona Pharma ADR

Last Updated:

Q3'20

Price

quotes and stock data delayed 15 minutes

Cash

$202M

Burn Rate (Qtr)

Company Profile

Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. We are currently focused on developing our novel lead therapeutic candidate in the treatment of chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF), and may expand our pipeline to help address the gaps in treatment of other respiratory diseases.

We are led by a team with deep industry experience, including extensive backgrounds in the discovery, development and commercialization of respiratory therapies. In addition, we have established relationships with leading research institutions and advocacy organizations in the respiratory space and have received awards in support of our continued work and innovation.

Verona Pharma is listed on the Nasdaq Global Market in the United States under the ticker symbol VRNA and on the London Stock Exchange in the United Kingdom under the ticker symbol VRP.L. We are headquartered in London and have offices in the United States.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

Ensifentrine (Nebulized)

Chronic obstructive pulmonary disease (COPD)

Phase 3 (Data)

H1 2021

Ensifentrine (Inhaled)

Chronic obstructive pulmonary disease (COPD)

Phase 2 (Data)

Ensifentrine (Inhaled)

COVID-19

Phase 2 (Data)

Ensifentrine (Nebulized)

Asthma

Phase 2 (Data)

Cystic Fibrosis

Ensifentrine (Nebulized)

Phase 2 (Data)

Recent Posts

See what the community is saying - click to see full post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon